Characterised by cough, coryza, conjunctivitis, a characteristic exanthem, and a pathognomonic enanthem (Koplik's spots).
Preventable by immunisation but high levels of coverage are required to prevent outbreaks of disease from occurring.
No specific treatment for measles is available except for supportive care.
Complications of measles are more common in immunocompromised and poorly nourished individuals and include pneumonia, laryngotracheitis, otitis media, and encephalitis.
Measles is a highly infectious disease caused by measles virus, characterised by a maculopapular rash, cough, coryza, conjunctivitis, and a pathognomonic enanthem (Koplik's spots) with an incubation period of about 10 days. There is no specific treatment of measles except for supportive care, but the disease can be prevented by a live virus vaccine. Complications of measles occur more often in immunocompromised and poorly nourished individuals and include pneumonia, laryngotracheitis, otitis media, and encephalitis. Measles is an epidemic disease prevalent worldwide. Its incidence has been curtailed markedly in countries where immunisation is widespread.
Professor of Pediatrics
Boston University School of Medicine
Boston Medical Center
EB is on the speakers' bureau of Merck and GlaxoSmithKline; has received reimbursements from Salix Pharmaceuticals and Novartis for consulting; has received research funding from Valneva (JE vaccine), PaxVax (cholera vaccine), and Cerexa (ceftaroline for pneumonia in children); served on a data safety monitoring board for Pfizer (pneumococcal vaccine); has received royalties from Elsevier (Immigrant Medicine), AAP (Nelson's pediatric antimicrobial therapy), and UptoDate (Immigrant screening); and has received honorarium from PaxVax (cholera vaccine advisory board).
Associate Professor of Pediatrics
West Virginia University School of Medicine
LN is an author of a reference cited in this monograph.
Assistant Professor of Medicine
Associate Residency Program Director
University of Chicago
AS declares that she has no competing interests.
Use of this content is subject to our disclaimer